comparemela.com
Home
Live Updates
Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths : comparemela.com
Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths
HF hospitalizations were reduced in all patients, yet only the higher-risk diabetic patients gained the survival advantage.
Related Keywords
New York ,
United States ,
Egypt ,
Benha ,
Al Qalyubiyah ,
American ,
Egyptian ,
Carlos Santos Gallego ,
Boehringer Ingelheim Eli Lilly ,
Ahmed Bendary ,
Astrazeneca ,
Md Benha University ,
Novartis ,
Egyptian Society Of Cardiology ,
Benha University ,
Crystal Clear Class ,
American Journal ,
Eli Lilly ,
Merck Sharp ,
Icahn School ,
Mount Sinai ,
Egyptian Society ,
comparemela.com © 2020. All Rights Reserved.